019736 S157 M1 1571
Document text
BioNTech RNA Pharmaceuticals GmbH 12/04/2020 An der Goldgrube 12 Mainz N/A Germany 55131215-280-5503 COVID-19 Vaccine (BNT162, PF-07302048)019736 Prophylactic immunization against COVID-19 in adults 16 years of age BB-IND 013812, BB-IND 013278, BLA 125549 0156 3 FDA-CBER-2021 5683-1072475 Özlem Türeci, MD, Chief Medical Officer, BioNTech SE Özlem Türeci, MD, Chief Medical Officer, BioNTech SE Elisa Harkins, Global Regulatory Lead, Pfizer Global Regulatory Affairs - Vaccines 215-280-5503 (845) 474-3500 500 Arcola Road Collegeville PA United States of America [email protected] 12/03/2020 United States of America 3 FDA-CBER-2021-5683-1072476 3 FDA-CBER-2021-5683-1072477